Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dongmei Zuo

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2009
Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancerMarisa G Ponzo, Robert Lesurf, Stephanie Petkiewicz, et al.
Breast Cancer Research : BCR|May 10, 2012
Crk adaptor proteins act as key signaling integrators for breast tumorigenesisKelly E Fathers, Emily S Bell, Charles V Rajadurai, et al.
Acta Biomaterialia|May 3, 2025
Invasive phenotypes of triple-negative breast cancer-associated fibroblasts are mechanosensitive, AhR-dependent and correlate with disease stateGabrielle Brewer, Paul Savage, Anne-Marie Fortier, et al.
Immunity|December 1, 2023
The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancerTarek Taifour, Sherif Samer Attalla, Dongmei Zuo, et al.
Scientific Reports|July 7, 2021
Assessing the post-treatment therapeutic effect of pinaverium in irritable bowel syndrome: a randomized controlled trialLiang Zheng, Weimin Lu, Qi Xiao, et al.
EMBO Reports|January 28, 2026
EZH2 directs HER2+ breast cancer progression through the modulation of epithelial plasticityLinshan Liu, Ellie J Massey, Dongmei Zuo, et al.
Cell Reports|October 10, 2019
Reduction of Global H3K27me<sup>3</sup> Enhances HER2/ErbB2 Targeted TherapyAlison Hirukawa, Salendra Singh, Jarey Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2020
An ErbB2 splice variant lacking exon 16 drives lung carcinomaHarvey W Smith, Lei Yang, Chen Ling, et al.
Plos One|January 31, 2008
A biomedically enriched collection of 7000 human ORF clonesAndreas Rolfs, Yanhui Hu, Lars Ebert, et al.
Cancer Immunology Research|June 13, 2023
HER2Δ16 Engages ENPP1 to Promote an Immune-Cold Microenvironment in Breast CancerSherif Samer Attalla, Jonathan Boucher, Hailey Proud, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Proceedings of the National Academy of Sciences of the United States of America|July 21, 2009
Met induces mammary tumors with diverse histologies and is associated with poor outcome and human basal breast cancerMarisa G Ponzo, Robert Lesurf, Stephanie Petkiewicz, et al.
Breast Cancer Research : BCR|May 10, 2012
Crk adaptor proteins act as key signaling integrators for breast tumorigenesisKelly E Fathers, Emily S Bell, Charles V Rajadurai, et al.
Acta Biomaterialia|May 3, 2025
Invasive phenotypes of triple-negative breast cancer-associated fibroblasts are mechanosensitive, AhR-dependent and correlate with disease stateGabrielle Brewer, Paul Savage, Anne-Marie Fortier, et al.
Immunity|December 1, 2023
The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancerTarek Taifour, Sherif Samer Attalla, Dongmei Zuo, et al.
Scientific Reports|July 7, 2021
Assessing the post-treatment therapeutic effect of pinaverium in irritable bowel syndrome: a randomized controlled trialLiang Zheng, Weimin Lu, Qi Xiao, et al.
EMBO Reports|January 28, 2026
EZH2 directs HER2+ breast cancer progression through the modulation of epithelial plasticityLinshan Liu, Ellie J Massey, Dongmei Zuo, et al.
Cell Reports|October 10, 2019
Reduction of Global H3K27me<sup>3</sup> Enhances HER2/ErbB2 Targeted TherapyAlison Hirukawa, Salendra Singh, Jarey Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2020
An ErbB2 splice variant lacking exon 16 drives lung carcinomaHarvey W Smith, Lei Yang, Chen Ling, et al.
Plos One|January 31, 2008
A biomedically enriched collection of 7000 human ORF clonesAndreas Rolfs, Yanhui Hu, Lars Ebert, et al.
Cancer Immunology Research|June 13, 2023
HER2Δ16 Engages ENPP1 to Promote an Immune-Cold Microenvironment in Breast CancerSherif Samer Attalla, Jonathan Boucher, Hailey Proud, et al.
Pageof 9